Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: Results from a large observational cohort study (BRiTE)

Axel Grothey, Mary M. Sugrue, David M. Purdie, Wei Dong, Daniel Sargent, Eric Hedrick, Mark Kozloff

Research output: Contribution to journal › Article › peer-review

595 Scopus citations

Fingerprint

Dive into the research topics of 'Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: Results from a large observational cohort study (BRiTE)'. Together they form a unique fingerprint.

Medicine & Life Sciences